GoodRx Holdings, Inc. (GDRX)
NASDAQ: GDRX · IEX Real-Time Price · USD
8.50
+0.44 (5.46%)
At close: Jul 19, 2024, 4:00 PM
8.51
+0.01 (0.12%)
Pre-market: Jul 22, 2024, 7:00 AM EDT
GoodRx Holdings Stock Forecast
Stock Price Forecast
The 20 analysts with 12-month price forecasts for GoodRx Holdings stock have an average target of 9.18, with a low estimate of 5.50 and a high estimate of 16. The average target predicts an increase of 8.00% from the current stock price of 8.50.
Analyst Consensus: Buy
* Price targets were last updated on Jun 10, 2024.
Analyst Ratings
The average analyst rating for GDRX stock from 20 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Buy | 2 | 5 | 6 | 8 | 8 | 8 |
| Hold | 10 | 9 | 8 | 7 | 8 | 8 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 17 | 17 | 19 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $7 → $9.5 | Hold | Maintains | $7 → $9.5 | +11.76% | Jun 10, 2024 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $8 → $10 | Hold → Buy | Upgrades | $8 → $10 | +17.65% | May 23, 2024 |
| Barclays | Barclays | Buy Maintains $9 → $10 | Buy | Maintains | $9 → $10 | +17.65% | May 20, 2024 |
| Raymond James | Raymond James | Hold → Buy Upgrades $10 | Hold → Buy | Upgrades | $10 | +17.65% | May 16, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +88.24% | May 16, 2024 |
Financial Forecast
Revenue This Year
822.66M
from 750.27M
Increased by 9.65%
Revenue Next Year
900.26M
from 822.66M
Increased by 9.43%
EPS This Year
0.37
from -0.02
EPS Next Year
0.46
from 0.37
Increased by 25.37%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 854.2M | 966.5M | 1.1B | 1.2B | 1.4B |
| Avg | 822.7M | 900.3M | 1.0B | 1.1B | 1.3B |
| Low | 787.9M | 823.0M | 873.8M | 1.1B | 1.3B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 13.9% | 17.5% | 21.5% | 19.1% | 19.8% |
| Avg | 9.6% | 9.4% | 11.3% | 14.2% | 15.0% |
| Low | 5.0% | 0.0% | -2.9% | 7.5% | 9.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.46 | 0.62 | 0.79 | 0.88 | 1.26 |
| Avg | 0.37 | 0.46 | 0.58 | 0.76 | 1.22 |
| Low | 0.31 | 0.36 | 0.47 | 0.64 | 1.18 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 67.7% | 70.1% | 51.4% | 65.8% |
| Avg | - | 25.4% | 25.9% | 30.4% | 61.1% |
| Low | - | -1.8% | 1.6% | 9.3% | 54.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.